Licensed antibody cell lines for large R&D, large scale production
cGMP development of hybrioma cell lines for inclusion in diagnostics, R&D and pre-clinal studies. Antibody processing and bulk production also available. In-depth screening and assay development feedback from team of specialized scientists. MBS licenses antibody cell lines for, and from, numerous organizations for use in pharmaceutical R&D and production.
Contract developer and producer of monoclonal and polyclonal antibodies
View profile